ANA Investigates Psychedelics & Unlocking Critical Periods

Listen as Dr. Adeline Goss, Associate Chief of Neurology at Highland Hospital, discusses the groundbreaking potential of psychedelics in neurology with Dr. Steve Zeiler, a Vascular Neurologist and Associate Professor at Johns Hopkins, and Dr. Ghul Dölen, a Professor of Psychology and Neuroscience at UC Berkeley. The conversation explores the newfound excitement surrounding psychedelics like MDMA, LSD, and psilocybin for treating mood disorders like depression and neurologic conditions such as stroke recovery. The experts also delve into research showing psychedelics' ability to reopen critical periods in the brain, potentially revolutionizing therapeutic approaches for a range of neurologic and psychiatric conditions. Series 5, Episode 11 Featuring: Guests: Dr. Steve Zeiler, a Vascular Neurologist and Associate Professor at Johns Hopkins, and Dr. Ghul Dölen, a Professor of Psychology and Neuroscience at UC Berkeley Interviewer: Dr. Adeline Goss, host & executive producer of ANA Investigates and Associate Chief of Neurology at Highland Hospital Disclosures: Dr. Dolen & Zeiler share a patent on their work in psychdelics and rehab. Dr. Zeiler also reports research funding from Harmon and EVER Pharma.